One Million Hits On iPatientCare’s Newly Launched ‘EHR Evaluation Tool’

Los Angeles, CA, August 26, 2014-- iPatientCare, Inc., a pioneer in mHealth and cloud-based ambulatory EHR and integrated Practice Management solutions announced its newly launched ‘EHR Evaluation Tool’ reaching to a million hits.

The innovative EHR evaluation tool developed by iPatientCare helps physicians to evaluate their current stage of EHR implementation with respect to usability, interoperability and credibility. Primarily, physician community is very keen in learning more about these important challenges; mainly usability, interoperability and credibility, and hence, the tool launched by iPatientCare has received an overwhelming response since it was launched on July 29th.

"The phenomenal response to our tool shows that enormous numbers of primary care physicians are very concerned to about their existing EHR software and implementations”, said John Bartley, MD, Chief Medical Director, iPatientCare. Adding further, he commented, “It is extremely concerning that the average satisfaction in existing EHR implementation computed by the tool is alarmingly low because of the existing EHR’s disappointing scores on satisfying typical practices’ needs for specialty-focus, customizable workflow and templates, communicating with labs, pharmacies and other physicians’ offices; and responsive and accountable implementation/training/ongoing support.”

Challenges faced while implementing EHR by small and medium sized practices have severe financial repercussions, and hence, practices across the nation wonder which EHR to choose from?

“iPatientCare has consistently worked on improving EHR features to make its EHR more usable for small and medium sized practices. Our focus on continuous user engagement has resulted in highly satisfied practices. We understand their needs around usability and interoperability which we serve through our talented people committed to delighting our customers,” said Udayan Mandavia, CEO, iPatientCare.

About EHR Evaluation Tool

iPatientCare is committed to provide personalized EHR and integrated Practice Solutions to small and medium sized practices. We understand the exact pains experienced by typical practices in implementing EHR/Practice Management Systems and Clinically-driven Revenue Cycle Management. The EHR Evaluation Tool is an attempt to assess the impact of existing EHR implementations on overall practice satisfaction with respect to usability, interoperability and credibility. We believe in continuous user engagement via numerous innovative forums/platforms that increase the possibilities of knowledge dissemination and getting to know the concerns of iPatientCare users.

About iPatientCare:

iPatientCare, Inc. is a privately held medical informatics company based at Woodbridge, New Jersey. The company’s unified product suite that include Electronic Health/Medical Record and integrated Practice Management/Billing System, Patient Portal/PHR, Health Information Exchange (HIE), and mobile point-of-care solutions for both ambulatory and acute/sub-acute market segments. iPatientCare has been recognized as a preferred/MU partner by numerous Regional Extension Centers (REC), hospitals/health systems, and academies, and additionally, has been designated as a Test EHR by the CMS.

iPatientCare EHR 2014 (2.0) has received 2014 Edition Ambulatory Complete EHR certification by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS).

Full certification details can be found at ONC Certified Health IT Product List.

IPatientCare Inpatient EHR 2014 (2.0) Received ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs, determines ability to support eligible hospitals with meeting meaningful use stage 1 and stage 2 measures required to qualify for ONC Health IT funding under the American Recovery and Reinvestment Act (ARRA).

Full certification details can be found at ONC Certified Health IT Product List.

The ONC 2014 Edition criteria support both Stage 1 and 2 Meaningful Use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

Visit http://www.iPatientCare.com for more information.

Contact:

iPatientCare, Inc.

One Woodbridge Center, Suite 812, Woodbridge, New Jersey 07095
Phone: 800-741-0981 | Fax: 732.676.7667 | Email: info(at)ipatientcare(dot)com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.